Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Chris A. Gentry"'
Publikováno v:
Journal of Infection. 86:248-255
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38788927b87784336e06bfe77741a378
https://doi.org/10.1016/j.jinf.2023.01.018
https://doi.org/10.1016/j.jinf.2023.01.018
Autor:
Chris A. Gentry, Charles M. Whitman, Brian S. Kliewer, Riley J. Williams, Sharanjeet K. Thind
Publikováno v:
International Journal of Antimicrobial Agents. 61:106752
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecc63fe62fff5ec5e129d210fd7f0d96
https://doi.org/10.1016/j.ijantimicag.2023.106752
https://doi.org/10.1016/j.ijantimicag.2023.106752
Autor:
Chris A. Gentry, Riley J. Williams, Charles M. Whitman, Sharanjeet K. Thind, Brian S. Kliewer
Publikováno v:
International Journal of Antimicrobial Agents. 61:106743
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8d46b04a50880effd6af789f69f4967
https://doi.org/10.1016/j.ijantimicag.2023.106743
https://doi.org/10.1016/j.ijantimicag.2023.106743
Autor:
Mary Beth Humphrey, George Kurdgelashvili, Sharanjeet Thind, Chris A. Gentry, Sage C Hendrickson, Riley J. Williams
Publikováno v:
The Lancet Rheumatology
Summary Background Hydroxychloroquine is one of several agents being evaluated in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to examine whether patients with rheumatological conditions receiving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c0a02d60bd50cb7869c0ac1e121696e
https://doi.org/10.1016/s2665-9913(20)30305-2
https://doi.org/10.1016/s2665-9913(20)30305-2
Publikováno v:
Open Forum Infectious Diseases
Background Lack of awareness of the taxonomic revision from the familiar Streptococcus bovis to the less familiar Streptococcus gallolyticus may be associated with a decrease in recommended colon cancer screening in patients with bacteremia from this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684f383f41845a396d59c2b640c396f9
http://europepmc.org/articles/PMC8458264
http://europepmc.org/articles/PMC8458264
Autor:
George Kurdgelashvili, Grant H. Skrepnek, Phuong Khanh Nguyen, Chris A. Gentry, Sharanjeet Thind, Riley J. Williams
Publikováno v:
Clinical Microbiology and Infection. 25:987-993
Objectives This study was conducted to compare clinical outcomes of fidaxomicin versus oral vancomycin in the management of severe Clostridium difficile infection (CDI). Methods The investigation was a retrospective, multicentre, propensity score-mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4adb0673a0460c5521692f402bf96dad
https://doi.org/10.1016/j.cmi.2018.12.007
https://doi.org/10.1016/j.cmi.2018.12.007
Publikováno v:
International journal of antimicrobial agents. 57(3)
Objectives The 2017 Society for Healthcare Epidemiology of America (SHEA) and Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for Clostridioides difficile (C. difficile) infection (CDI) removed metronidazole as a preferred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa95c6f77bd8ab16101489c25923cc78
https://pubmed.ncbi.nlm.nih.gov/33465458
https://pubmed.ncbi.nlm.nih.gov/33465458
Publikováno v:
Diagnostic microbiology and infectious disease. 100(2)
In 2018, we demonstrated a decreased prevalence of the hypervirulent Clostridioides difficile BI/NAP1/027 strain across the United States (US) Veterans Health Administration (VHA) from 2011 through 2016. The objective of this retrospective study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b0cc894d9d29279e317c7f08b11412
https://pubmed.ncbi.nlm.nih.gov/33626478
https://pubmed.ncbi.nlm.nih.gov/33626478
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 44:220-228
What is known and objective Recurrent Clostridium difficile infection (CDI) occurs after initial treatment in approximately 20%-30% of patients, regardless of therapy chosen. The objective of this study was to assess clinical outcomes of recurrent CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b16795f8f05c5a5596efb7296e58c20
https://doi.org/10.1111/jcpt.12771
https://doi.org/10.1111/jcpt.12771
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 24(8)
Objectives The increased incidence and severity of Clostridium difficile infection (CDI) are thought to result partly from the emergence of the hypervirulent BI/NAP1/027 strain. Limited recent data are available on the prevalence of BI/NAP1/027 in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddd30457d03f29fba30a5c5ac4fb028b
https://pubmed.ncbi.nlm.nih.gov/29174729
https://pubmed.ncbi.nlm.nih.gov/29174729